Stock Price Forecast

May 1, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading InspireMD, Inc. chart...

About the Company

We do not have any company description for InspireMD, Inc. at the moment.

Exchange

Nasdaq

$10M

Total Revenue

56

Employees

$43M

Market Capitalization

-1.72

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NSPR News

InspireMD, Inc.

3mon ago, source: CNN

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and ...

Why Are InspireMD Shares Surging Today

11mon ago, source: Hosted on MSN

InspireMD Inc. (NASDAQ: NSPR) shares are surging Monday after the company said it had inked a pact with healthcare-focused institutional investors that have agreed to provide up to $113.6 million ...

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

1mon ago, source: Yahoo Finance

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke ...

InspireMD Inc. Common Stock (NSPR)

9y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

InspireMD, Inc. (II2.F)

2mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

InspireMD, Inc. (NSPR)

9d ago, source: Yahoo Finance

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke ...

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

1mon ago, source: Investing

About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet ® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable ...

InspireMD Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...